ArticleDrugs - real world outcomes2015
Polypharmacy Among the Elderly in a List-Patient System.
Article in Drugs - real world outcomes, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.
- The Relationship of Continuity of Care, Polypharmacy and Medication Appropriateness: A Systematic Review of Observational Studies.Drugs & aging · 2023Pooled it
- What is polypharmacy? A systematic review of definitions.BMC geriatrics · 2017Pooled it
- Drug prescription before and after dialysis initiation in older patients: a nationwide study.BMC geriatrics · 2026Article
- Longitudinal cohort study of discrepancies between prescribed and administered polypharmacy rates: implications for National Aged Care Quality Indicator Programs.BMJ quality & safety · 2024Article
- Degree of Polypharmacy and Cognitive Function in Older Women with HIV.AIDS research and human retroviruses · 2022Article
- Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences.European geriatric medicine · 2021Review
- Mapping Drug Prescription, Polypharmacy, and Pharmaceutical Spending in Older Adults in Iran: A Multilevel Analysis Based on Claims Data.Medical journal of the Islamic Republic of Iran · 2021Article
- Polypharmacy Management in the Older Adults: A Scoping Review of Available Interventions.Frontiers in pharmacology · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolypharmacy, i.e. the simultaneous use of multiple drugs, is known to be associated with compliance errors and adverse drug reactions. Norway has a list-patient system in general practice, formalizing the relationship between the patient and his/her regular general practitioner (GP). One important aim with a list-patient system is to secure medical quality in primary care by giving the GP the responsibility for coordinating the medical treatment.
objectiveTo examine the regular GP's role in polypharmacy to the home-dwelling elderly in Norway and to determine by how much multiple prescribers increase the risk of polypharmacy.
methodsThis was a population registry study based on data on all prescription drugs dispensed at pharmacies to patients 70 years and older from the Norwegian Prescription Database, merged with data on GPs and GPs' patient lists from the Regular General Practitioner Database. The dataset included 624,308 patients and 4520 GPs in the period from 2004 to 2007. Outcome measures were: number of drug-substances prescribed and dispensed per patient by the regular GP, other GPs, non-GP specialists and hospital doctors; polypharmacy, defined as five or more prescribed and dispensed substances in the same quarter; excessive polypharmacy, defined as ten or more prescribed and dispensed substances in the same quarter.
resultsPolypharmacy is high and increasing despite the list-patient system. GPs prescribe all the substances that cause polypharmacy in 64 % of the incidents, but the patients' risk of polypharmacy increases substantially with number of prescribers, odds ratio 2.32 (95 % CI 2.31-2.33).
conclusionGPs have a major role in the high and increasing polypharmacy among the elderly in Norway. Any intervention intending to improve the situation must necessarily include the GPs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.